Glial Activation and Expression of the Serotonin Transporter in Chronic Fatigue Syndrome

November 16, 2018Frontiers in PsychiatryOpen Access

View Full Paper

Ask AI

Bookmark

Share

Key Points

Investigate the involvement of glial activation, serotonin transporter expression, and specific receptor subtypes in chronic fatigue syndrome.
Examined neuroinflammation pathways involving glial activation and serotonin transporter dynamics in chronic fatigue syndrome.
Evaluated candidate receptor subtypes as potential mechanistic and therapeutic drug targets.
Identifies neuroimmune glial activation and altered serotonin transporter expression as core features of chronic fatigue syndrome pathophysiology.
Demonstrates that therapeutic modulation of specific receptor subtypes within these pathways represents a promising avenue for drug development.

Answers are grounded in this paper and cite their sources.

Translational review reveals neuroimmune and serotonin alterations in chronic fatigue syndrome, highlighting novel targets for disease therapy.

No abstract yet. The journal hasn't published one we can show.

No takes yet. Share an insight, caveat, or question.

Noda et al. (2018) studied this question.

View Full Paper

Ask AI

Bookmark

Share